TY  - JOUR

T1  - Re: Enzalutamide with Standard First-line Therapy in Metastatic Prostate Cancer

JO  - European Urology

PY  - 2019/01/01

AU  - Butcher G

AU  - Howard H

AU  - Sathianathen N

AU  - Catto JWF

AU  - Murphy DG

ED  - 

DO  - DOI: 10.1016/j.eururo.2019.07.018

PB  - Elsevier BV

VL  - 76

IS  - 6

SP  - 872

EP  - 873

Y2  - 2024/10/23

ER  -